Equity Overview
Price & Market Data
Price: $0.025
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $61,761,500
Daily Volume: 0
Performance Metrics
1 Week: -51.36%
1 Month: -26.25%
3 Months: -33.16%
6 Months: -37.97%
1 Year: -49.90%
YTD: -37.50%
Company Details
Employees: 83
Sector: Health technology
Industry: Medical specialties
Country:
Details
ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California.